Mkts

ImmunityBio, Inc.

NASDAQ: IBRX
$8.29-0.45 (-5.15%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
8.128.72
52-week range
1.9512.43
Today
Open8.48
Previous close8.29
Volume—
Valuation
Market cap8.79B
P/E ratio—
EPS (TTM)-0.97
Income & risk
Dividend / yield—
Beta0.20
Avg volume11.47M
Discussion

IBRX News

Stories mentioning IBRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue44,20638,28532,06126,42516,5177,5526,1061,047
Cost of Goods Sold238.00382.00177.00136.0058.000.000.000.00
Gross Profit43,96837,90331,88426,28916,4597,5526,1061,047
Operating Expenses
Research & Development35,22150,44351,129
Sales General & Admin41,73135,91649,251
Total Operating Expenses76,95286,359100,380
Operating Income (Loss)(69,791)(64,683)(55,630)(71,285)(64,429)(69,400)(80,253)(99,333)
Interest Income
Interest Expense14,84315,25615,47415,31326,02129,32229,787
Other Expense(5,917)(1,668)(187.00)(278.00)(41.00)10.0012.00(17.00)
Pretax Income(632,788)(62,093)(67,309)(92,305)(129,900)(59,179)(85,752)(134,584)
Tax Provision9.00(135.00)(35.00)269.00(234.00)0.000.000.00
Net Income (Loss)(632,782)(61,944)(67,253)(92,555)(129,646)(59,162)(85,729)(134,564)
Earnings Per Share (Basic)(0.62)(0.07)(0.07)(0.10)(0.15)(0.08)(0.12)(0.20)
Earnings Per Share (Diluted)(0.62)(0.07)(0.07)(0.10)(0.15)(0.08)(0.14)(0.20)
Weighted Average Shares Outstanding (Basic)1,026,874919,863946,601888,216853,162697,312695,895686,938
Weighted Average Shares Outstanding (Diluted)1,026,874919,863946,601888,216853,162700,443697,961686,938

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IBRX

ImmunityBio, Inc. (NASDAQ: IBRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol IBRX. It last traded at $8.29 (Oct 30, 2026, 4:00 PM ET), down 5.2% on the day. That gives ImmunityBio a market capitalisation of $8.8B.

Over the past 52 weeks IBRX has traded between $1.95 and $12.43.

Revenue for the quarter ended Mar 31, 2026 was $44.2M; a net loss of $632.8M. Revenue was up 168% from $16.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$44.2M-$632.8M-1431.4%
Dec 31, 2025$38.3M-$61.9M-161.8%
Sep 30, 2025$32.1M-$67.3M-209.8%
Jun 30, 2025$26.4M-$92.6M-350.3%

From ImmunityBio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…